Table 1

Illustrative indicators from the SRH Self-Care Measurement Tool, by intervention and measurement domain

DomainNo.Indicator namePurposeWhere it’s being used
 Enabling environment4Status of policy that authorises private sector staff to initiate SIExpanding access by reaching women who tend to rely on the private sector for their contraceptive methodsRoutine reporting for the DMPA-SC Donor Consortium:
Access Collaborative dashboard (; AC country briefs (
 KAP (knowledge)12Percentage of women aged 15–49 who have heard of a self-injectable contraceptiveGauging knowledge as a precursor for informed decision-makingThe Performance Monitoring for Action (PMA) surveys (
 KAP (practices)18Among current DMPA-SC users, percentage of women aged 15–49 who self-injected their current methodUnderstanding prevalence of SIThe Performance Monitoring for Action (PMA) surveys (
 Service delivery and health outcomes20Number and percentage of service delivery points (SDPs) actively offering SI servicesMeasuring availability and access, including geographic scope of availability of SI servicesRoutine reporting for the DMPA-SC Donor Consortium Access Collaborative dashboard & SI quarterly report (
HIV self-testing indicators
 Enabling environment33Number of HIVST products approved annually, among those with WHO prequalificationUnderstanding number of HIVST kits pre-qualified (PQed) or listed by Stringent Regulatory Authority (SRA)/Expert Review Panel for Diagnostics (ERPD).Collected biannually by WHO
 KAP (knowledge)38Percentage of HIVST users who would recommend HIVST to a friendMeasuring client satisfaction which covers both their satisfaction with the actual product (ease of use) as well as their satisfaction with the information they received to prepare them to use the productPSI’s Strengthening HIVST in the Private Sector (SHIPS) project. Data are collected through opt-in chatbot surveys but could also be collected through a more widespread consumer survey
 Service delivery and health outcomes49Number of people newly enrolled on antiretroviral therapy who report self-test useEstimating impact of HIVST through use in data triangulationUsually collected in national DHIS2
Self-managed abortion
 Enabling environment53National essential medicines list includes combination mifepristone and misoprostol, or misoprostol and mifepristone as separate presentationsIdentifying targets to strive for or maintain in area of medicines and other health productsGAPD; IPPF Medical Abortion
Commodities Database WHO/HRP multi-country initiative health system monitoring
 KAP (knowledge)56Percentage of individuals who understand what to expect at each step of the self-managed abortion processEnsuring quality of abortion care, specifically provision of information to prepare clientsACQTool, indicator #21 (
 Service delivery and health outcomes61Percentage of respondents who reported feeling prepared to determine if their abortion was completeFacilitating quality SMA requires information and support about abortion completeness. This includes effective communication and preparednessField-tested and validated as part of
ACQ project
ACQTool, indicator #24 (
  • AC, Access Collaborative; ACQ, Abortion Care Quality; DHIS2, District Health Information Software; DMPA, subcutaneous depot medroxyprogesterone acetate; GAPD, Global Abortion Policies Database; HIVST, HIV self-testing; HRP, Human Reproduction Programme; IPPF, International Planned Parenthood Federation; KAP, knowledge, attitude, practices; PSI, Population Services International; SI, self-injection; SMA, self-managed abortion; SRH, sexual and reproductive health.